$1.11 -0.09 (-7.50%)
2/10/2012 4:00 PM

AVI BioPharma, Inc. (NASDAQ:AVII)

CAPS Rating: 2 out of 5

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

Featured Broker Partners


Advertisement